Ji Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ji Cheng has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Haoyue Deng
Department of Dermatology & Medical Aesthetics, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, China
2 shared publications - Jianjun Zhang
Department of Gynecology and Obstetrics Nursing, West China Second University Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu City, Sichuan Province, China
2 shared publications - Jingna Zhang
Department of Palliative Medicine, West China Fourth Hospital, Sichuan University, Chengdu, China
2 shared publications - Lina Duo
Department of Dermatology & Medical Aesthetics, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, China
2 shared publications - Musi Zhang
Department of Radiation Oncology, Sichuan Cancer Hospital&Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
2 shared publications - Taiguo Liu
Department of Oncology, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, China
2 shared publications
Latest Publications
- Open Access
- 23 April 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e82902
Use and Influencing Factors of mHealth Services Among Adult Survivors of Cancer: Cross-Sectional Survey Study
Background: The growing number of survivors of cancer in China has created an increasing need for survivorship care as many survivors face ongoing physical, psychological, and social challenges after treatment. Mobile health (mHealth) services, which are delivered through mobile devices and apps, have emerged as potential tools to support self-management, facilitate access to care, and improve quality of life. However, evidence on the prevalence, use patterns, and determinants of mHealth adoption among Chinese survivors of cancer remains limited. Objective: This study aimed to examine the prevalence and patterns of mHealth use among adult survivors of cancer in China and identify sociodemographic and clinical factors associated with adoption. Methods: We conducted a multicenter cross-sectional survey study between February 13, 2024, and September 21, 2024, at 4 tertiary cancer care centers in China. Adult survivors of cancer were recruited using convenience sampling. Data were collected through structured face-to-face questionnaires assessing sociodemographic and clinical characteristics, mHealth use, perceived needs, concerns, and user experience. Missing data were limited and handled using complete-case analysis after the Little test supported consistency with missing completely at random. Descriptive analyses summarized participant characteristics and mHealth-related variables. Group differences were examined using chi-square tests and 2-tailed independent-sample t tests. Significant variables in univariate analyses were entered into a multivariable logistic regression model. Results: Of 1152 participants, 364 (31.6%) reported prior mHealth use. Use was concentrated in practical functions, particularly appointment booking (301/364, 82.7%), online consultation (244/364, 67%), and viewing examination or laboratory reports (215/364, 59.1%), with WeChat-based platforms being the most commonly used access channel (244/364, 67%). Participants reported high demand for clinical guidance (917/1152, 79.6%) and direct communication with health care professionals (901/1152, 78.2%), whereas common concerns included leakage of private information (694/1152, 60.2%) and inaccurate illness judgment (633/1152, 54.9%). In multivariable analysis, mHealth use was significantly associated with younger age, higher educational level, annual household income of at least ¥100,000 (US $14,527.90), widowed or divorced marital status, living alone, and treatment dissatisfaction; cancer type and time since diagnosis were not significant predictors. Conclusions: mHealth use among adult survivors of cancer in China is established but uneven, with use concentrated in practical service functions rather than comprehensive survivorship support. Uptake was significantly associated with age, socioeconomic position, social circumstances, and treatment experience but not with clinical characteristics. Survivors reported a strong demand for clinically relevant and communication-oriented functions but also expressed substantial concerns about privacy, accuracy, reimbursement, and physician authenticity. Future survivorship mHealth services should prioritize clinical relevance, trust, integration with formal care, and equitable implementation to achieve broader and more meaningful use.
- 23 April 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e82902
Open AccessUse and Influencing Factors of mHealth Services Among Adult Survivors of Cancer: Cross-Sectional Survey Study
Background: The growing number of survivors of cancer in China has created an increasing need for survivorship care as many survivors face ongoing physical, psychological, and social challenges after treatment. Mobile health (mHealth) services, which are delivered through mobile devices and apps, have emerged as potential tools to support self-management, facilitate access to care, and improve quality of life. However, evidence on the prevalence, use patterns, and determinants of mHealth adoption among Chinese survivors of cancer remains limited. Objective: This study aimed to examine the prevalence and patterns of mHealth use among adult survivors of cancer in China and identify sociodemographic and clinical factors associated with adoption. Methods: We conducted a multicenter cross-sectional survey study between February 13, 2024, and September 21, 2024, at 4 tertiary cancer care centers in China. Adult survivors of cancer were recruited using convenience sampling. Data were collected through structured face-to-face questionnaires assessing sociodemographic and clinical characteristics, mHealth use, perceived needs, concerns, and user experience. Missing data were limited and handled using complete-case analysis after the Little test supported consistency with missing completely at random. Descriptive analyses summarized participant characteristics and mHealth-related variables. Group differences were examined using chi-square tests and 2-tailed independent-sample t tests. Significant variables in univariate analyses were entered into a multivariable logistic regression model. Results: Of 1152 participants, 364 (31.6%) reported prior mHealth use. Use was concentrated in practical functions, particularly appointment booking (301/364, 82.7%), online consultation (244/364, 67%), and viewing examination or laboratory reports (215/364, 59.1%), with WeChat-based platforms being the most commonly used access channel (244/364, 67%). Participants reported high demand for clinical guidance (917/1152, 79.6%) and direct communication with health care professionals (901/1152, 78.2%), whereas common concerns included leakage of private information (694/1152, 60.2%) and inaccurate illness judgment (633/1152, 54.9%). In multivariable analysis, mHealth use was significantly associated with younger age, higher educational level, annual household income of at least ¥100,000 (US $14,527.90), widowed or divorced marital status, living alone, and treatment dissatisfaction; cancer type and time since diagnosis were not significant predictors. Conclusions: mHealth use among adult survivors of cancer in China is established but uneven, with use concentrated in practical service functions rather than comprehensive survivorship support. Uptake was significantly associated with age, socioeconomic position, social circumstances, and treatment experience but not with clinical characteristics. Survivors reported a strong demand for clinically relevant and communication-oriented functions but also expressed substantial concerns about privacy, accuracy, reimbursement, and physician authenticity. Future survivorship mHealth services should prioritize clinical relevance, trust, integration with formal care, and equitable implementation to achieve broader and more meaningful use.
- Open Access
- 24 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Use and Influencing Factors of mHealth Services Among Adult Survivors of Cancer: Cross-Sectional Survey Study (Preprint)
BACKGROUND The growing number of survivors of cancer in China has created an increasing need for survivorship care as many survivors face ongoing physical, psychological, and social challenges after treatment. Mobile health (mHealth) services, which are delivered through mobile devices and apps, have emerged as potential tools to support self-management, facilitate access to care, and improve quality of life. However, evidence on the prevalence, use patterns, and determinants of mHealth adoption among Chinese survivors of cancer remains limited. OBJECTIVE This study aimed to examine the prevalence and patterns of mHealth use among adult survivors of cancer in China and identify sociodemographic and clinical factors associated with adoption. METHODS We conducted a multicenter cross-sectional survey study between February 13, 2024, and September 21, 2024, at 4 tertiary cancer care centers in China. Adult survivors of cancer were recruited using convenience sampling. Data were collected through structured face-to-face questionnaires assessing sociodemographic and clinical characteristics, mHealth use, perceived needs, concerns, and user experience. Missing data were limited and handled using complete-case analysis after the Little test supported consistency with missing completely at random. Descriptive analyses summarized participant characteristics and mHealth-related variables. Group differences were examined using chi-square tests and 2-tailed independent-sample t tests. Significant variables in univariate analyses were entered into a multivariable logistic regression model. RESULTS Of 1152 participants, 364 (31.6%) reported prior mHealth use. Use was concentrated in practical functions, particularly appointment booking (301/364, 82.7%), online consultation (244/364, 67%), and viewing examination or laboratory reports (215/364, 59.1%), with WeChat-based platforms being the most commonly used access channel (244/364, 67%). Participants reported high demand for clinical guidance (917/1152, 79.6%) and direct communication with health care professionals (901/1152, 78.2%), whereas common concerns included leakage of private information (694/1152, 60.2%) and inaccurate illness judgment (633/1152, 54.9%). In multivariable analysis, mHealth use was significantly associated with younger age, higher educational level, annual household income of at least ¥100,000 (US $14,527.90), widowed or divorced marital status, living alone, and treatment dissatisfaction; cancer type and time since diagnosis were not significant predictors. CONCLUSIONS mHealth use among adult survivors of cancer in China is established but uneven, with use concentrated in practical service functions rather than comprehensive survivorship support. Uptake was significantly associated with age, socioeconomic position, social circumstances, and treatment experience but not with clinical characteristics. Survivors reported a strong demand for clinically relevant and communication-oriented functions but also expressed substantial concerns about privacy, accuracy, reimbursement, and physician authenticity. Future survivorship mHealth services should prioritize clinical relevance, trust, integration with formal care, and equitable implementation to achieve broader and more meaningful use.
- 24 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUse and Influencing Factors of mHealth Services Among Adult Survivors of Cancer: Cross-Sectional Survey Study (Preprint)
BACKGROUND The growing number of survivors of cancer in China has created an increasing need for survivorship care as many survivors face ongoing physical, psychological, and social challenges after treatment. Mobile health (mHealth) services, which are delivered through mobile devices and apps, have emerged as potential tools to support self-management, facilitate access to care, and improve quality of life. However, evidence on the prevalence, use patterns, and determinants of mHealth adoption among Chinese survivors of cancer remains limited. OBJECTIVE This study aimed to examine the prevalence and patterns of mHealth use among adult survivors of cancer in China and identify sociodemographic and clinical factors associated with adoption. METHODS We conducted a multicenter cross-sectional survey study between February 13, 2024, and September 21, 2024, at 4 tertiary cancer care centers in China. Adult survivors of cancer were recruited using convenience sampling. Data were collected through structured face-to-face questionnaires assessing sociodemographic and clinical characteristics, mHealth use, perceived needs, concerns, and user experience. Missing data were limited and handled using complete-case analysis after the Little test supported consistency with missing completely at random. Descriptive analyses summarized participant characteristics and mHealth-related variables. Group differences were examined using chi-square tests and 2-tailed independent-sample t tests. Significant variables in univariate analyses were entered into a multivariable logistic regression model. RESULTS Of 1152 participants, 364 (31.6%) reported prior mHealth use. Use was concentrated in practical functions, particularly appointment booking (301/364, 82.7%), online consultation (244/364, 67%), and viewing examination or laboratory reports (215/364, 59.1%), with WeChat-based platforms being the most commonly used access channel (244/364, 67%). Participants reported high demand for clinical guidance (917/1152, 79.6%) and direct communication with health care professionals (901/1152, 78.2%), whereas common concerns included leakage of private information (694/1152, 60.2%) and inaccurate illness judgment (633/1152, 54.9%). In multivariable analysis, mHealth use was significantly associated with younger age, higher educational level, annual household income of at least ¥100,000 (US $14,527.90), widowed or divorced marital status, living alone, and treatment dissatisfaction; cancer type and time since diagnosis were not significant predictors. CONCLUSIONS mHealth use among adult survivors of cancer in China is established but uneven, with use concentrated in practical service functions rather than comprehensive survivorship support. Uptake was significantly associated with age, socioeconomic position, social circumstances, and treatment experience but not with clinical characteristics. Survivors reported a strong demand for clinically relevant and communication-oriented functions but also expressed substantial concerns about privacy, accuracy, reimbursement, and physician authenticity. Future survivorship mHealth services should prioritize clinical relevance, trust, integration with formal care, and equitable implementation to achieve broader and more meaningful use.
- Open Access
- 27 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (43) , e35781
Disseminated disease caused by Mycobacterium marseillense: A case report and literature review
Rationale: Among numerous types of nontuberculous mycobacterial infections, Mycobacterium avium complex is a related group of species, which can cause various diseases in humans. Mycobacterium marseillense is a member of the Mycobacterium avium complex, which accounts for only a small proportion of species, but causes rare diseases affecting the lungs, lymph nodes, skin, and tendon sheath. So far, very few cases have been reported. Patient concerns: A 76-year-old male of peculiar skin infection. Metagenomic Next Generation Sequencing and bacterial culture of skin secretions revealed M marseillense. To the best of our knowledge, we report the first patient diagnosed with disseminated M marseillense infection. Here, we identified only 8 other reports of patients with M marseillense infection. Diagnoses: Disseminated M marseillense infection. Interventions: The patient was treated with clarithromycin, rifampicin, moxifloxacin, and ethambutol. Outcomes: The skin lesions of the patient showed significant improvement, and his pruritus and limb pain were notably reduced after 7 months of follow-up. Lessons: Metagenomic Next Generation Sequencing may be a useful tool to diagnose M marseillense infection, but the results should be confirmed by culture and mycobacterial identification.
- 27 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (43) , e35781
Open AccessDisseminated disease caused by Mycobacterium marseillense: A case report and literature review
Rationale: Among numerous types of nontuberculous mycobacterial infections, Mycobacterium avium complex is a related group of species, which can cause various diseases in humans. Mycobacterium marseillense is a member of the Mycobacterium avium complex, which accounts for only a small proportion of species, but causes rare diseases affecting the lungs, lymph nodes, skin, and tendon sheath. So far, very few cases have been reported. Patient concerns: A 76-year-old male of peculiar skin infection. Metagenomic Next Generation Sequencing and bacterial culture of skin secretions revealed M marseillense. To the best of our knowledge, we report the first patient diagnosed with disseminated M marseillense infection. Here, we identified only 8 other reports of patients with M marseillense infection. Diagnoses: Disseminated M marseillense infection. Interventions: The patient was treated with clarithromycin, rifampicin, moxifloxacin, and ethambutol. Outcomes: The skin lesions of the patient showed significant improvement, and his pruritus and limb pain were notably reduced after 7 months of follow-up. Lessons: Metagenomic Next Generation Sequencing may be a useful tool to diagnose M marseillense infection, but the results should be confirmed by culture and mycobacterial identification.
- 2 September 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (12) , e415-e417
Exon 8 deletion of KRT5 in epidermolysis bullosa simplex with mottled pigmentation: A case report
- 2 September 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (12) , e415-e417
Exon 8 deletion of KRT5 in epidermolysis bullosa simplex with mottled pigmentation: A case report